| ‘Anytime, anywhere’: vaping as social practice H Keane, M Weier, D Fraser, C Gartner Critical Public Health 27 (4), 465-476, 2017 | 81 | 2017 |
| Vapers’ perspectives on electronic cigarette regulation in Australia D Fraser, M Weier, H Keane, C Gartner International Journal of Drug Policy 26 (6), 589-594, 2015 | 51 | 2015 |
| Preferences for current and future PrEP modalities among PrEP-experienced gay and bisexual men in Australia C Chan, S Vaccher, D Fraser, AE Grulich, M Holt, I Zablotska-Manos, ... AIDS and Behavior 26 (1), 88-95, 2022 | 27 | 2022 |
| Interference from related actions in spoken word production: Behavioural and fMRI evidence G de Zubicaray, D Fraser, K Ramajoo, K McMahon Neuropsychologia 96, 78-88, 2017 | 22 | 2017 |
| Assessing the place of neurobiological explanations in accounts of a family member's addiction C Meurk, D Fraser, M Weier, J Lucke, A Carter, W Hall Drug and Alcohol Review 35 (4), 461-469, 2016 | 16 | 2016 |
| Patterns of tobacco smoking among illicit drug users in A ustralia 2001–2010 D Fraser, C Gartner, W Hall Drug and alcohol review 33 (5), 534-539, 2014 | 12 | 2014 |
| Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: results from the MI-EPIC clinical trial C Chan, D Fraser, S Vaccher, B Yeung, F Jin, J Amin, NJ Dharan, A Carr, ... Sexual Health 18 (6), 453-459, 2021 | 10 | 2021 |
| A pragmatic randomized comparative trial of e-cigarettes and other nicotine products for quitting or long-term substitution in smokers K Morphett, D Fraser, R Borland, W Hall, N Walker, C Bullen, C Gartner Nicotine and Tobacco Research 24 (7), 1079-1088, 2022 | 9 | 2022 |
| Protocol for a randomised pragmatic policy trial of nicotine products for quitting or long-term substitution in smokers D Fraser, R Borland, C Gartner BMC Public Health 15, 1-9, 2015 | 7 | 2015 |
| Early and late electrophysiological effects of distractor frequency in picture naming: Reconciling input and output accounts SK Riès, D Fraser, KL McMahon, GI De Zubicaray Journal of Cognitive Neuroscience 27 (10), 1936-1947, 2015 | 7 | 2015 |
| Incorrect knowledge of event-driven PrEP “2-1-1” dosing regimen among PrEP-experienced gay and bisexual men in Australia C Chan, S Vaccher, D Fraser, AE Grulich, M Holt, I Zablotska-Manos, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 90 (2), 132-139, 2022 | 6 | 2022 |
| Increased awareness of event-driven PrEP and knowledge of how to use it: results from a cross-sectional survey of gay and bisexual men in Australia C Chan, D Fraser, AE Grulich, S Philpot, M Vaughan, M Wacher, ... Sexual Health 19 (6), 501-508, 2022 | 5 | 2022 |
| Once‐daily oxycodone prolonged‐release tablets are resistant to alcohol‐induced dose dumping: results from a randomized trial in healthy volunteers N Burger, D Fraser, MA Maritz, J Faulkner, H Rey Clinical and Translational Science 13 (3), 539-546, 2020 | 5 | 2020 |
| Report on the PrEP in NSW Transition Study, 2018-2020 D Fraser Kirby Institute, 2020 | 5 | 2020 |
| Switching to non-daily pre-exposure prophylaxis among gay and bisexual men in Australia: implications for improving knowledge, safety, and uptake SP Philpot, D Murphy, C Chan, B Haire, D Fraser, AE Grulich, ... Sexuality Research and Social Policy 19 (4), 1979-1988, 2022 | 4 | 2022 |
| Discontinuation of government subsidized HIV pre‐exposure prophylaxis in Australia: a whole‐of‐population analysis of dispensing records NA Medland, D Fraser, BR Bavinton, F Jin, AE Grulich, H Paynter, R Guy, ... Journal of the International AIDS Society 26 (1), e26056, 2023 | 3 | 2023 |
| Sustaining sexual and reproductive health through COVID-19 pandemic restrictions: qualitative interviews with Australian clinicians CE Newman, D Fraser, JJ Ong, C Bourne, AE Grulich, BR Bavinton Sexual Health 19 (6), 525-532, 2022 | 3 | 2022 |
| Attitudes towards treatment as prevention among PrEP-experienced gay and bisexual men in Australia A Dowell-Day, T Dobbins, C Chan, D Fraser, M Holt, SJ Vaccher, B Clifton, ... AIDS and Behavior 27 (9), 2969-2978, 2023 | 2 | 2023 |
| Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis–Experienced Gay and Bisexual Men in … T Arapali, AE Grulich, AE Heywood, C Chan, D Fraser, IB Zablotska, ... Sexually Transmitted Diseases 50 (3), 144-149, 2023 | 2 | 2023 |
| Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection … KL Seib, B Donovan, C Thng, DA Lewis, A McNulty, CK Fairley, B Yeung, ... BMJ open 14 (4), e081675, 2024 | | 2024 |
